A detailed history of Keystone Investors Pte LTD transactions in Zai Lab LTD stock. As of the latest transaction made, Keystone Investors Pte LTD holds 55,210 shares of ZLAB stock, worth $1.59 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
55,210
Holding current value
$1.59 Million
% of portfolio
0.42%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025

BUY
$24.32 - $43.03 $1.34 Million - $2.38 Million
55,210 New
55,210 $1.93 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.82B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Keystone Investors Pte LTD Portfolio

Follow Keystone Investors Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Investors Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Keystone Investors Pte LTD with notifications on news.